ZCT Zero Candida Technologies, Inc.
Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.…
Industry Peers
Medical DevicesKey Statistics
About Zero Candida Technologies (CVE: ZCT)
›
Zero Candida Technologies (CVE: ZCT) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.
The shares were at 0.1050 CAD on 18 November 2026, down 60.4% over 52 weeks. Its 52-week range is 0.1050 CAD to 0.2800 CAD, and it trades at the bottom of that range.
Its market capitalisation is 2.05M CAD.
Zero Candida Technologies reports return on equity of -74.1% and an operating margin of 0.0%.
Its Piotroski F-score is 4 out of 9, an average reading of its financial health.